Clinical Trial Update: LIFE-DSR-Biomarker Sub-study of Biomarkers in Down Syndrome Related Alzheimer's Disease (DS-AD) [Phase 3]

View source ↗

Summary

Phase 3 LIFE-DSR biomarker sub-study evaluating biomarkers in Down syndrome-related Alzheimer's disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Down Syndrome

Snippet

Sponsor: LuMind IDSC Foundation | Conditions: Down Syndrome | Phase 3 | Status: TERMINATED